These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23891229)

  • 1. Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
    Shmalenyuk ER; Chernousova LN; Karpenko IL; Kochetkov SN; Smirnova TG; Andreevskaya SN; Chizhov AO; Efremenkova OV; Alexandrova LA
    Bioorg Med Chem; 2013 Sep; 21(17):4874-84. PubMed ID: 23891229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
    Matyugina E; Khandazhinskaya A; Chernousova L; Andreevskaya S; Smirnova T; Chizhov A; Karpenko I; Kochetkov S; Alexandrova L
    Bioorg Med Chem; 2012 Nov; 20(22):6680-6. PubMed ID: 23062712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
    Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel 5-(ethyl or hydroxymethyl) analogs of 2'-'up' fluoro (or hydroxyl) pyrimidine nucleosides as a new class of Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium avium inhibitors.
    Shakya N; Srivastav NC; Bhavanam S; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    Bioorg Med Chem; 2012 Jul; 20(13):4088-97. PubMed ID: 22664188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antituberculosis agents. V. Synthesis, evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(5-nitro-2-furyl)-1,3,4-thiadiazole derivatives.
    Foroumadi A; Asadipour A; Mirzaei M; Karimi J; Emami S
    Farmaco; 2002 Sep; 57(9):765-9. PubMed ID: 12385528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines.
    Tonelli M; Novelli F; Tasso B; Sparatore A; Boido V; Sparatore F; Cannas S; Molicotti P; Zanetti S; Parapini S; Loddo R
    Bioorg Med Chem; 2014 Dec; 22(24):6837-45. PubMed ID: 25464882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4,5-Dihydro-1H-pyrazolo[3,4-d]pyrimidine containing phenothiazines as antitubercular agents.
    Siddiqui AB; Trivedi AR; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1493-5. PubMed ID: 24582983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel 5-alkynyl pyrimidine nucleosides derivatives: Influence of C-6-substituent on antituberculosis activity.
    Volov AN; Volov NA; Platonova YB
    Bioorg Med Chem Lett; 2021 Sep; 48():128261. PubMed ID: 34265421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
    Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
    Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
    Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.
    Saquib M; Husain I; Sharma S; Yadav G; Singh VK; Sharma SK; Shah P; Siddiqi MI; Kumar B; Lal J; Jain GK; Srivastava BS; Srivastava R; Shaw AK
    Eur J Med Chem; 2011 Jun; 46(6):2217-23. PubMed ID: 21440336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
    Braendvang M; Bakken V; Gundersen LL
    Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial activity of novel 1-(5-cyclobutyl-1,3-oxazol-2-yl)-3-(sub)phenyl/pyridylthiourea compounds endowed with high activity toward multidrug-resistant Mycobacterium tuberculosis.
    Sriram D; Yogeeswari P; Dinakaran M; Thirumurugan R
    J Antimicrob Chemother; 2007 Jun; 59(6):1194-6. PubMed ID: 17449482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enantiopure antituberculosis candidates synthesized from (-)-fenchone.
    Dobrikov GM; Valcheva V; Nikolova Y; Ugrinova I; Pasheva E; Dimitrov V
    Eur J Med Chem; 2014 Apr; 77():243-7. PubMed ID: 24642567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of new quinoxaline-2-carboxylate 1,4-dioxide derivatives as anti-Mycobacterium tuberculosis agents.
    Jaso A; Zarranz B; Aldana I; Monge A
    J Med Chem; 2005 Mar; 48(6):2019-25. PubMed ID: 15771444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antimycobacterial activity of new quinoxaline-2-carboxamide 1,4-di-N-oxide derivatives.
    Zarranz B; Jaso A; Aldana I; Monge A
    Bioorg Med Chem; 2003 May; 11(10):2149-56. PubMed ID: 12713824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.